{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:19:33Z","timestamp":1793024373779,"version":"4.5.0"},"reference-count":50,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Context<\/jats:italic>\n                    .\u2014Cap-mediated messenger RNA translation controlled by the eukaryotic initiation factor 4F (eIF-4F) complex plays a key role in human cancer. eIF-4F activity is controlled by a repressor binding protein (4E-BP1), which promotes translation when phosphorylated.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objective<\/jats:italic>\n                    .\u2014To examine the level of expression and phosphorylation of 4E-BP1 in various subtypes of B-cell lymphoma and reactive lymphoid tissues.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Design<\/jats:italic>\n                    .\u2014Archival formalin-fixed, paraffin-embedded B-cell lymphoma samples and reactive lymphoid tissues were immunostained and examined for expression of 4E-BP1 and phosphorylated 4E-BP1. Expression of components of the eIF-4F complex and unphosphorylated and phosphorylated 4E-BP1 was confirmed using Western immunoblotting on lysates of frozen lymphoma samples and reactive tissues.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    .\u2014Immunohistochemical analysis demonstrated weak to undetectable 4E-BP1 staining within benign, reactive germinal centers (N \u200a=\u200a 10). In contrast, 4E-BP1 was consistently expressed (moderate to strong staining) in 98% of various subtypes of mature B-cell lymphoma (N \u200a=\u200a 50). 4E-BP1 expression was also demonstrable in all 4 lymph nodes with in situ or partial involvement by follicular lymphoma and in all 12 cases of BCL2-negative lymphoma. The level of phosphorylation of 4E-BP1 in lymphomas, evaluated by immunohistochemistry, was heterogeneous.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions<\/jats:italic>\n                    .\u2014The immunohistochemical expression pattern of 4E-BP1 exhibits regional and cellular specificity in reactive lymphoid tissues and may offer a diagnostic tool for distinguishing reactive follicles from neoplastic B-cell proliferations.\n                  <\/jats:p>","DOI":"10.5858\/2009-0759-oa.1","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T13:11:11Z","timestamp":1613135471000},"page":"365-371","source":"Crossref","is-referenced-by-count":15,"title":["Expression and Phosphorylation of Eukaryotic Translation Initiation Factor 4E Binding Protein 1 in B-Cell Lymphomas and Reactive Lymphoid Tissues"],"prefix":"10.5858","volume":"135","author":[{"given":"Dhatri","family":"Kodali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J","family":"Ninan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish R","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Kratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"5","key":"i1543-2165-135-3-365-b01","series-title":"Nat Rev Mol Cell Biol","first-page":"307","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma\n              XM,","year":"2009","unstructured":"Ma\n              XM, \n            \n              Blenis\n              J. \n          \n          Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10(5):307\u2013318."},{"issue":"16","key":"i1543-2165-135-3-365-b02","series-title":"Cancer Res","first-page":"7551","article-title":"4E-binding protein 1: a key molecular \u201cfunnel factor\u201d in human cancer with clinical implications","volume":"67","author":"Armengol\n              G,","year":"2007","unstructured":"Armengol\n              G, \n            \n              Rojo\n              F, \n            \n              Castellvi\n              J, \n            et al. \n          4E-binding protein 1: a key molecular \u201cfunnel factor\u201d in human cancer with clinical implications. Cancer Res. 2007;67(16):7551\u20137555."},{"issue":"1","key":"i1543-2165-135-3-365-b03","series-title":"Cancer Lett","first-page":"1","article-title":"Translational control: a target for cancer therapy","volume":"258","author":"Thumma\n              SC,","year":"2007","unstructured":"Thumma\n              SC, \n            \n              Kratzke\n              RA. \n          \n          Translational control: a target for cancer therapy. Cancer Lett. 2007;258(1):1\u20138."},{"issue":"3","key":"i1543-2165-135-3-365-b04","series-title":"Clin Exp Metastasis","first-page":"265","article-title":"Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs","volume":"20","author":"Graff\n              JR,","year":"2003","unstructured":"Graff\n              JR, \n            \n              Zimmer\n              SG. \n          \n          Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis. 2003;20(3):265\u2013273."},{"issue":"2","key":"i1543-2165-135-3-365-b05","series-title":"Oncol Rep","first-page":"281","article-title":"Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray","volume":"17","author":"Yang\n              SX,","year":"2007","unstructured":"Yang\n              SX, \n            \n              Hewitt\n              SM, \n            \n              Steinberg\n              SM, \n            \n              Liewehr\n              DJ, \n            \n              Swain\n              SM. \n          \n          Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep. 2007;17(2):281\u2013287."},{"issue":"24","key":"i1543-2165-135-3-365-b06","series-title":"Genes Dev","first-page":"3232","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Wendel\n              HG,","year":"2007","unstructured":"Wendel\n              HG, \n            \n              Silva\n              RL, \n            \n              Malina\n              A, \n            et al. \n          Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007;21(24):3232\u20133237."},{"issue":"6980","key":"i1543-2165-135-3-365-b07","series-title":"Nature","first-page":"332","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel\n              HG,","year":"2004","unstructured":"Wendel\n              HG, \n            \n              De Stanchina\n              E, \n            \n              Fridman\n              JS, \n            et al. \n          Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004;428(6980):332\u2013337."},{"issue":"3","key":"i1543-2165-135-3-365-b08","series-title":"Cancer Res","first-page":"631","article-title":"Targeting the eukaryotic translation initiation factor 4E for cancer therapy","volume":"68","author":"Graff\n              JR,","year":"2008","unstructured":"Graff\n              JR, \n            \n              Konicek\n              BW, \n            \n              Carter\n              JH, \n            \n              Marcusson\n              EG. \n          \n          Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res. 2008;68(3):631\u2013634."},{"issue":"9","key":"i1543-2165-135-3-365-b09","series-title":"Cancer Res","first-page":"3866","article-title":"eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival","volume":"69","author":"Graff\n              JR,","year":"2009","unstructured":"Graff\n              JR, \n            \n              Konicek\n              BW, \n            \n              Lynch\n              RL, \n            et al. \n          eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res. 2009;69(9):3866\u20133873."},{"issue":"9","key":"i1543-2165-135-3-365-b10","series-title":"J Clin Invest","first-page":"2638","article-title":"Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity","volume":"117","author":"Graff\n              JR,","year":"2007","unstructured":"Graff\n              JR, \n            \n              Konicek\n              BW, \n            \n              Vincent\n              TM, \n            et al. \n          Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest. 2007;117(9):2638\u20132648."},{"issue":"2","key":"i1543-2165-135-3-365-b11","series-title":"Cell","first-page":"257","article-title":"Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G","volume":"128","author":"Moerke\n              NJ,","year":"2007","unstructured":"Moerke\n              NJ, \n            \n              Aktas\n              H, \n            \n              Chen\n              H, \n            et al. \n          Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell. 2007;128(2):257\u2013267."},{"issue":"2","key":"i1543-2165-135-3-365-b12","series-title":"Blood","first-page":"257","article-title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","volume":"114","author":"Assouline\n              S,","year":"2009","unstructured":"Assouline\n              S, \n            \n              Culjkovic\n              B, \n            \n              Cocolakis\n              E, \n            et al. \n          Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood. 2009;114(2):257\u2013260."},{"issue":"9","key":"i1543-2165-135-3-365-b13","series-title":"Clin Cancer Res","first-page":"2756","article-title":"A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies","volume":"14","author":"Rizzieri\n              DA,","year":"2008","unstructured":"Rizzieri\n              DA, \n            \n              Feldman\n              E, \n            \n              Dipersio\n              JF, \n            et al. \n          A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2008;14(9):2756\u20132762."},{"issue":"7","key":"i1543-2165-135-3-365-b14","series-title":"J Clin Invest","first-page":"2651","article-title":"Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model","volume":"118","author":"Bordeleau\n              ME,","year":"2008","unstructured":"Bordeleau\n              ME, \n            \n              Robert\n              F, \n            \n              Gerard\n              B, \n            et al. \n          Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest. 2008;118(7):2651\u20132660."},{"issue":"8","key":"i1543-2165-135-3-365-b15","series-title":"Cancer Res","first-page":"4256","article-title":"Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo","volume":"66","author":"Jacobson\n              BA,","year":"2006","unstructured":"Jacobson\n              BA, \n            \n              Alter\n              MD, \n            \n              Kratzke\n              MG, \n            et al. \n          Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Res. 2006;66(8):4256\u20134262."},{"issue":"3","key":"i1543-2165-135-3-365-b16","series-title":"Br J Cancer","first-page":"424","article-title":"Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma","volume":"101","author":"Jacobson\n              BA,","year":"2009","unstructured":"Jacobson\n              BA, \n            \n              De\n              A, \n            \n              Kratzke\n              MG, \n            et al. \n          Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer. 2009;101(3):424\u2013431."},{"issue":"5","key":"i1543-2165-135-3-365-b17","series-title":"Nat Med","first-page":"484","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Ruggero\n              D,","year":"2004","unstructured":"Ruggero\n              D, \n            \n              Montanaro\n              L, \n            \n              Ma\n              L, \n            et al. \n          The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004;10(5):484\u2013486."},{"issue":"1","key":"i1543-2165-135-3-365-b18","series-title":"Am J Pathol","first-page":"247","article-title":"Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas","volume":"155","author":"Wang\n              S,","year":"1999","unstructured":"Wang\n              S, \n            \n              Rosenwald\n              IB, \n            \n              Hutzler\n              MJ, \n            et al. \n          Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol. 1999;155(1):247\u2013255."},{"issue":"6","key":"i1543-2165-135-3-365-b19","series-title":"J Huazhong Univ Sci Technol Med Sci","first-page":"636","article-title":"Relationship between eukaryotic translation initiation factor 4E and malignant angiogenesis in non-Hodgkin lymphoma","volume":"25","author":"Zhao\n              Y,","year":"2005","unstructured":"Zhao\n              Y, \n            \n              Liu\n              W, \n            \n              Zhou\n              S, \n            \n              Zhou\n              J, \n            \n              Sun\n              H. \n          \n          Relationship between eukaryotic translation initiation factor 4E and malignant angiogenesis in non-Hodgkin lymphoma. J Huazhong Univ Sci Technol Med Sci. 2005;25(6):636\u2013638."},{"issue":"6","key":"i1543-2165-135-3-365-b20","series-title":"Am J Pathol","first-page":"2171","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi\n              E,","year":"2006","unstructured":"Peponi\n              E, \n            \n              Drakos\n              E, \n            \n              Reyes\n              G, \n            \n              Leventaki\n              V, \n            \n              Rassidakis\n              GZ, \n            \n              Medeiros\n              LJ. \n          \n          Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol. 2006;169(6):2171\u20132180."},{"issue":"7","key":"i1543-2165-135-3-365-b21","series-title":"Blood","first-page":"2667","article-title":"Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells","volume":"110","author":"Kawamata\n              N,","year":"2007","unstructured":"Kawamata\n              N, \n            \n              Chen\n              J, \n            \n              Koeffler\n              HP. \n          \n          Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. Blood. 2007;110(7):2667\u20132673."},{"issue":"21","key":"i1543-2165-135-3-365-b22","series-title":"Genes Dev","first-page":"2852","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras\n              AC,","year":"2001","unstructured":"Gingras\n              AC, \n            \n              Raught\n              B, \n            \n              Gygi\n              SP, \n            et al. \n          Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 2001;15(21):2852\u20132864."},{"issue":"4","key":"i1543-2165-135-3-365-b23","series-title":"Int J Oncol","first-page":"893","article-title":"Pharmacogenomic profiling of the PI3K\/PTEN-AKT-mTOR pathway in common human tumors","volume":"24","author":"Xu\n              G,","year":"2004","unstructured":"Xu\n              G, \n            \n              Zhang\n              W, \n            \n              Bertram\n              P, \n            \n              Zheng\n              XF, \n            \n              McLeod\n              H. \n          \n          Pharmacogenomic profiling of the PI3K\/PTEN-AKT-mTOR pathway in common human tumors. Int J Oncol. 2004;24(4):893\u2013900."},{"issue":"2","key":"i1543-2165-135-3-365-b24","series-title":"Am J Pathol","first-page":"817","article-title":"Activation of mTORC1 signaling pathway in AIDS-related lymphomas","volume":"175","author":"El-Salem\n              M,","year":"2009","unstructured":"El-Salem\n              M, \n            \n              Raghunath\n              PN, \n            \n              Marzec\n              M, \n            et al. \n          Activation of mTORC1 signaling pathway in AIDS-related lymphomas. Am J Pathol. 2009;175(2):817\u2013824."},{"issue":"22:764","key":"i1543-2165-135-3-365-b25","series-title":"Blood","article-title":"Translation regulatory protein 4E-binding protein (BP)-1 phosphorylation identifies diffuse large B cell lymphoma patients with low IPI scores who experience short survival after chemotherapy [abstract 1925]","volume":"114","author":"Ninan\n              M,","year":"2009","unstructured":"Ninan\n              M, \n            \n              Rawal\n              A, \n            \n              Mesa\n              H, \n            \n              Knapp\n              D, \n            \n              Gupta\n              P. \n          \n          Translation regulatory protein 4E-binding protein (BP)-1 phosphorylation identifies diffuse large B cell lymphoma patients with low IPI scores who experience short survival after chemotherapy [abstract 1925]. Blood. 2009;114(22:764) ."},{"issue":"5","key":"i1543-2165-135-3-365-b01","series-title":"Nat Rev Mol Cell Biol","first-page":"307","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma\n              XM,","year":"2009","unstructured":"Ma\n              XM, \n            \n              Blenis\n              J. \n          \n          Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10(5):307\u2013318."},{"issue":"16","key":"i1543-2165-135-3-365-b02","series-title":"Cancer Res","first-page":"7551","article-title":"4E-binding protein 1: a key molecular \u201cfunnel factor\u201d in human cancer with clinical implications","volume":"67","author":"Armengol\n              G,","year":"2007","unstructured":"Armengol\n              G, \n            \n              Rojo\n              F, \n            \n              Castellvi\n              J, \n            et al. \n          4E-binding protein 1: a key molecular \u201cfunnel factor\u201d in human cancer with clinical implications. Cancer Res. 2007;67(16):7551\u20137555."},{"issue":"1","key":"i1543-2165-135-3-365-b03","series-title":"Cancer Lett","first-page":"1","article-title":"Translational control: a target for cancer therapy","volume":"258","author":"Thumma\n              SC,","year":"2007","unstructured":"Thumma\n              SC, \n            \n              Kratzke\n              RA. \n          \n          Translational control: a target for cancer therapy. Cancer Lett. 2007;258(1):1\u20138."},{"issue":"3","key":"i1543-2165-135-3-365-b04","series-title":"Clin Exp Metastasis","first-page":"265","article-title":"Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs","volume":"20","author":"Graff\n              JR,","year":"2003","unstructured":"Graff\n              JR, \n            \n              Zimmer\n              SG. \n          \n          Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis. 2003;20(3):265\u2013273."},{"issue":"2","key":"i1543-2165-135-3-365-b05","series-title":"Oncol Rep","first-page":"281","article-title":"Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray","volume":"17","author":"Yang\n              SX,","year":"2007","unstructured":"Yang\n              SX, \n            \n              Hewitt\n              SM, \n            \n              Steinberg\n              SM, \n            \n              Liewehr\n              DJ, \n            \n              Swain\n              SM. \n          \n          Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep. 2007;17(2):281\u2013287."},{"issue":"24","key":"i1543-2165-135-3-365-b06","series-title":"Genes Dev","first-page":"3232","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Wendel\n              HG,","year":"2007","unstructured":"Wendel\n              HG, \n            \n              Silva\n              RL, \n            \n              Malina\n              A, \n            et al. \n          Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007;21(24):3232\u20133237."},{"issue":"6980","key":"i1543-2165-135-3-365-b07","series-title":"Nature","first-page":"332","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel\n              HG,","year":"2004","unstructured":"Wendel\n              HG, \n            \n              De Stanchina\n              E, \n            \n              Fridman\n              JS, \n            et al. \n          Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004;428(6980):332\u2013337."},{"issue":"3","key":"i1543-2165-135-3-365-b08","series-title":"Cancer Res","first-page":"631","article-title":"Targeting the eukaryotic translation initiation factor 4E for cancer therapy","volume":"68","author":"Graff\n              JR,","year":"2008","unstructured":"Graff\n              JR, \n            \n              Konicek\n              BW, \n            \n              Carter\n              JH, \n            \n              Marcusson\n              EG. \n          \n          Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res. 2008;68(3):631\u2013634."},{"issue":"9","key":"i1543-2165-135-3-365-b09","series-title":"Cancer Res","first-page":"3866","article-title":"eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival","volume":"69","author":"Graff\n              JR,","year":"2009","unstructured":"Graff\n              JR, \n            \n              Konicek\n              BW, \n            \n              Lynch\n              RL, \n            et al. \n          eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res. 2009;69(9):3866\u20133873."},{"issue":"9","key":"i1543-2165-135-3-365-b10","series-title":"J Clin Invest","first-page":"2638","article-title":"Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity","volume":"117","author":"Graff\n              JR,","year":"2007","unstructured":"Graff\n              JR, \n            \n              Konicek\n              BW, \n            \n              Vincent\n              TM, \n            et al. \n          Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest. 2007;117(9):2638\u20132648."},{"issue":"2","key":"i1543-2165-135-3-365-b11","series-title":"Cell","first-page":"257","article-title":"Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G","volume":"128","author":"Moerke\n              NJ,","year":"2007","unstructured":"Moerke\n              NJ, \n            \n              Aktas\n              H, \n            \n              Chen\n              H, \n            et al. \n          Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell. 2007;128(2):257\u2013267."},{"issue":"2","key":"i1543-2165-135-3-365-b12","series-title":"Blood","first-page":"257","article-title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","volume":"114","author":"Assouline\n              S,","year":"2009","unstructured":"Assouline\n              S, \n            \n              Culjkovic\n              B, \n            \n              Cocolakis\n              E, \n            et al. \n          Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood. 2009;114(2):257\u2013260."},{"issue":"9","key":"i1543-2165-135-3-365-b13","series-title":"Clin Cancer Res","first-page":"2756","article-title":"A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies","volume":"14","author":"Rizzieri\n              DA,","year":"2008","unstructured":"Rizzieri\n              DA, \n            \n              Feldman\n              E, \n            \n              Dipersio\n              JF, \n            et al. \n          A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2008;14(9):2756\u20132762."},{"issue":"7","key":"i1543-2165-135-3-365-b14","series-title":"J Clin Invest","first-page":"2651","article-title":"Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model","volume":"118","author":"Bordeleau\n              ME,","year":"2008","unstructured":"Bordeleau\n              ME, \n            \n              Robert\n              F, \n            \n              Gerard\n              B, \n            et al. \n          Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest. 2008;118(7):2651\u20132660."},{"issue":"8","key":"i1543-2165-135-3-365-b15","series-title":"Cancer Res","first-page":"4256","article-title":"Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo","volume":"66","author":"Jacobson\n              BA,","year":"2006","unstructured":"Jacobson\n              BA, \n            \n              Alter\n              MD, \n            \n              Kratzke\n              MG, \n            et al. \n          Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Res. 2006;66(8):4256\u20134262."},{"issue":"3","key":"i1543-2165-135-3-365-b16","series-title":"Br J Cancer","first-page":"424","article-title":"Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma","volume":"101","author":"Jacobson\n              BA,","year":"2009","unstructured":"Jacobson\n              BA, \n            \n              De\n              A, \n            \n              Kratzke\n              MG, \n            et al. \n          Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer. 2009;101(3):424\u2013431."},{"issue":"5","key":"i1543-2165-135-3-365-b17","series-title":"Nat Med","first-page":"484","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Ruggero\n              D,","year":"2004","unstructured":"Ruggero\n              D, \n            \n              Montanaro\n              L, \n            \n              Ma\n              L, \n            et al. \n          The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004;10(5):484\u2013486."},{"issue":"1","key":"i1543-2165-135-3-365-b18","series-title":"Am J Pathol","first-page":"247","article-title":"Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas","volume":"155","author":"Wang\n              S,","year":"1999","unstructured":"Wang\n              S, \n            \n              Rosenwald\n              IB, \n            \n              Hutzler\n              MJ, \n            et al. \n          Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol. 1999;155(1):247\u2013255."},{"issue":"6","key":"i1543-2165-135-3-365-b19","series-title":"J Huazhong Univ Sci Technol Med Sci","first-page":"636","article-title":"Relationship between eukaryotic translation initiation factor 4E and malignant angiogenesis in non-Hodgkin lymphoma","volume":"25","author":"Zhao\n              Y,","year":"2005","unstructured":"Zhao\n              Y, \n            \n              Liu\n              W, \n            \n              Zhou\n              S, \n            \n              Zhou\n              J, \n            \n              Sun\n              H. \n          \n          Relationship between eukaryotic translation initiation factor 4E and malignant angiogenesis in non-Hodgkin lymphoma. J Huazhong Univ Sci Technol Med Sci. 2005;25(6):636\u2013638."},{"issue":"6","key":"i1543-2165-135-3-365-b20","series-title":"Am J Pathol","first-page":"2171","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi\n              E,","year":"2006","unstructured":"Peponi\n              E, \n            \n              Drakos\n              E, \n            \n              Reyes\n              G, \n            \n              Leventaki\n              V, \n            \n              Rassidakis\n              GZ, \n            \n              Medeiros\n              LJ. \n          \n          Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol. 2006;169(6):2171\u20132180."},{"issue":"7","key":"i1543-2165-135-3-365-b21","series-title":"Blood","first-page":"2667","article-title":"Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells","volume":"110","author":"Kawamata\n              N,","year":"2007","unstructured":"Kawamata\n              N, \n            \n              Chen\n              J, \n            \n              Koeffler\n              HP. \n          \n          Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. Blood. 2007;110(7):2667\u20132673."},{"issue":"21","key":"i1543-2165-135-3-365-b22","series-title":"Genes Dev","first-page":"2852","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras\n              AC,","year":"2001","unstructured":"Gingras\n              AC, \n            \n              Raught\n              B, \n            \n              Gygi\n              SP, \n            et al. \n          Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 2001;15(21):2852\u20132864."},{"issue":"4","key":"i1543-2165-135-3-365-b23","series-title":"Int J Oncol","first-page":"893","article-title":"Pharmacogenomic profiling of the PI3K\/PTEN-AKT-mTOR pathway in common human tumors","volume":"24","author":"Xu\n              G,","year":"2004","unstructured":"Xu\n              G, \n            \n              Zhang\n              W, \n            \n              Bertram\n              P, \n            \n              Zheng\n              XF, \n            \n              McLeod\n              H. \n          \n          Pharmacogenomic profiling of the PI3K\/PTEN-AKT-mTOR pathway in common human tumors. Int J Oncol. 2004;24(4):893\u2013900."},{"issue":"2","key":"i1543-2165-135-3-365-b24","series-title":"Am J Pathol","first-page":"817","article-title":"Activation of mTORC1 signaling pathway in AIDS-related lymphomas","volume":"175","author":"El-Salem\n              M,","year":"2009","unstructured":"El-Salem\n              M, \n            \n              Raghunath\n              PN, \n            \n              Marzec\n              M, \n            et al. \n          Activation of mTORC1 signaling pathway in AIDS-related lymphomas. Am J Pathol. 2009;175(2):817\u2013824."},{"issue":"22:764","key":"i1543-2165-135-3-365-b25","series-title":"Blood","article-title":"Translation regulatory protein 4E-binding protein (BP)-1 phosphorylation identifies diffuse large B cell lymphoma patients with low IPI scores who experience short survival after chemotherapy [abstract 1925]","volume":"114","author":"Ninan\n              M,","year":"2009","unstructured":"Ninan\n              M, \n            \n              Rawal\n              A, \n            \n              Mesa\n              H, \n            \n              Knapp\n              D, \n            \n              Gupta\n              P. \n          \n          Translation regulatory protein 4E-binding protein (BP)-1 phosphorylation identifies diffuse large B cell lymphoma patients with low IPI scores who experience short survival after chemotherapy [abstract 1925]. Blood. 2009;114(22:764) ."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/3\/article-p365.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/3\/365\/2770800\/2009-0759-oa_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/135\/3\/article-p365.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/135\/3\/article-p365.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:11:43Z","timestamp":1770772303000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/3\/article-p365.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":50,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5858\/2009-0759-oa.1","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}